Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses
Samantha Epstein, Seth Levin, Kaho Onomichi, Christopher Langston, Anusha K. Yeshokumar, Michelle Fabian, Ilana Katz Sand, Sylvia Klineova, Fred Lublin, Kiersten Dykstra, Zongqi Xia, Philip L. De Jager, L. Levine, Rebecca Straus Farber, Claire Riley, Wendy Vargas
Topics & Concepts
MedicineMyelin oligodendrocyte glycoproteinMultiple sclerosisDiseaseInternal medicineLogistic regressionOptic neuritisTransverse myelitisRetrospective cohort studyPediatricsImmunologyGastroenterologyExperimental autoimmune encephalomyelitisMultiple Sclerosis Research StudiesAutoimmune Neurological Disorders and TreatmentsPeripheral Neuropathies and Disorders